|
Vol. 07 • Na. 1 • March 2005
In this issue:
Buprenorphine induction and stabilisation in the treatment of opiate dependence
Doran C., Holmes J., Ladewig D., Ling W.
Clinical significance of electroencephalographic abnormalities in heroin addicts: Systematic review
Polunina A. G., Davydov D. M., Briun E. A.
Alcohol abuse in heroin addicts: An unfolding metabolic destiny
Pacini M., Mellini A., Attilia M. L., Ceccanti M., Maremmani I.
Symptomatic treatment of opiate withdrawal syndrome by low-dose buprenorphine in an in-patient setting
Fuscone A., Correale M., Romualdo M., Bianchi W.
Open letter to physicians and other health care providers facing pain management during opioid agonist therapy with methadone
Payte J. T.
|
|
Vol. 07 • Na. 2 • June 2005
In this issue:
Methadone maintenance treatment and mood disturbances: Pharmacological and psychological implications
Dyer K. R.
Long-term treatment for patients with severe mental illness and substance abuse
Blix O., Eek U.
Good practice, good results. Maintenance treatment outcomes in France
Coppel A.
The endogenous cannabinoid system: Physiological modulation of neuronal activity
Marsicano G.
Substitution treatment in European prisons. A study of policies and practices of substitution treatment in prison in 18 European countries
Hennebel L. C., Stöver
Medical meaning of psychosocial issues of heroin addiction
Pacini M., Maremmani I.
|
|
Vol. 07 • Na. 3 • September 2005
In this issue:
Psychotherapy for patients in methadone treatment
Bignamini E., Zazza S.
Buprenorphine high-dose, broad spectrum, long-term treatment: A new clinical approach to opiate alkaloid dependency
Di Petta G., Leonardi C.
Correlation between high methadone dose and methadone blood level in methadone maintenance treatment patients
Peles E., Bodner G., Adelson M.
Addictive disorders, bipolar spectrum and the impulsive link: The psychopathology of a self-regenerating pathway
Maremmani I., Pacini M., Perugi G.
Bridging the preclinical - clinical gap
Nutt D. J., Lingford-Hughes A., Daglish M., Williams T., Taylor L., Wilson S., Davies S., Melichar J., Myles J.
Mortality and retention of drug users in GP Shared Care in Glasgow
Gilhooly T.
Working with the patient for optimal treatment outcomes in UK General Practice
Ford C., Oliver J., Whitehead B.
|
|
Vol. 07 • Na. 4 • December 2005
In this issue:
Addiction and Pregnancy
Finnegan L., Amass L., Jones H., Kaltenbach K.
Primary care physicians and addiction treatment in Germany. Decentralization and take-home policy
Ulmer A.
Psychopathological disorders in heroin addicts and administration of risperidone during rehabilitation
Kozlov A. A., Dorovskih I. V., Doljanskaia N. A., Buzina T. S., Polunina A. G.
Methadone reduces the need for antipsychotic and antimanic agents in heroin addicts hospitalized for manic and/or acute psychotic episodes
Pacini M., Maremmani I.
Methadone serum concentration and its relationship to methadone dose revisited
Okruhlica L., Valentova J., Devinsky F., Formakova S., Klempova D.
Medical and social factors determining early poly-drug dependence
Chernobrovkina T. V., Igor A. Nikiforov I. A.
|